Icon continued their run of solid quarterly results, reporting an operating income of US $23.0 million, an increase of 96.0% year on year. Net revenues were also higher, at US $316.8 million. The income total included reorganisation, and other items amounting to US $4.41 million. Without these charges operating income was up to US $27.4
Continuing its move from transactional relationships to strategic alliances with clients, ICON have announced that they have been chosen by Roche as Roche’s technology partner for storing and managing medical images collected during clinical research programmes. ICON is an international supplier of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company
